Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Levitra receives FDA approval

Aug. 25, 2003

Preliminary results of North American Cystistat trial for interstitial cystitis

Aug. 22, 2003

Improved safety profile for transdermal oxybutynin vs. oral tolterodine in overactive bladder

Aug. 19, 2003

Yamanouchi and GlaxoSmithKline to copromote Vesicare in U.S.

Aug. 13, 2003

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Aug. 12, 2003

Levitra is effective in men of diverse ethnic origin

Aug. 11, 2003

Collaborative Study Group to conduct KRX-101 phase II/III program

Aug. 7, 2003

Sustained symptom relief induced by tamsulosin in BPH

Aug. 1, 2003

Enrollment completed in phase IIb at-home study of PT-141

July 29, 2003

Preclinical evaluation of A-350619: a potential novel treatment for sexual dysfunction

July 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...